HFM Investment Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$328 1284
2025
Q4
$328 Hold
2
﹤0.01% 857
2025
Q3
$267 Hold
2
﹤0.01% 908
2025
Q2
$249 Hold
2
﹤0.01% 915
2025
Q1
$255 Buy
+2
New +$308 ﹤0.01% 536

Other funds holding RGEN

HFM Investment Advisors's RGEN Position: Q1 2026 in Review

HFM Investment Advisors sold out of Repligen (RGEN) in Q1 2026, closing a stake of 2 shares — an estimated $328 sold.

HFM Investment Advisors first reported a position in RGEN in Q1 2025 and held it in 4 quarters. The position peaked at $328 in Q4 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • HFM Investment Advisors reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • HFM Investment Advisors sold 2 Repligen shares in Q1 2026, an estimated $328.
  • HFM Investment Advisors first reported a position in Repligen in Q1 2025 and held it in 4 quarters.
  • HFM Investment Advisors's Repligen position peaked at $328 in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.